The excitatory:inhibitory ratio model (EIR model):: An integrative explanation of acute autonomic overactivity syndromes

被引:102
作者
Baguley, Ian J. [1 ]
机构
[1] Westmead Hosp, Brain Injury Rehabil Serv, Wentworthville, NSW 2145, Australia
关键词
D O I
10.1016/j.mehy.2007.04.037
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Numerous medical conditions present with acute and severe autonomic and muscular overactivity. These syndromes include Neuroleptic Malignant Syndrome, Serotonin Syndrome, Dysautonomia (or paroxysmal sympathetic storms) following acquired brain injury, Autonomic Dysreflexia, Parkinsonian-Hyperpyrexia Syndrome, Malignant Catatonia, intrathecal baclofen withdrawal, Malignant Hyperthermia, Stiff Man Syndrome and Irukandji Syndrome. In their worst forms, each of these syndromes are relatively rare, are treated by different medical specialties and show widely varying pathophysiology. Most are considered to be medical emergencies and share significant mortality rates. Previous authors have noted similarities between some of these conditions, prompting the suggestion that a single common mechanism may underlie their clinical presentation. However, the development of such an integrative model has not occurred. This paper presents a short review of the clinical syndromes, grouped by the location of pathology and mechanism of action. From this background, an integrative framework termed the excitatory: inhibitory ratio (EIR) model is presented. The EIR model consists of two inter-retated networks operating at spinal and brainstem levels. The model is evaluated against pre-clinical scientific research, known pathways, each disorder's pathophysiology (where this is known) and variable severity, and used to explain the reasons behind the efficacy of current treatment regimes. Circumstantial evidence for an expanded aetiology for Malignant Hyperthermia is provided and generic treatment strategies for a number of other conditions are suggested. Finally, minor modifications to this model provide a basis to begin to explain less severe, regional "overlap" syndromes. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:26 / 35
页数:10
相关论文
共 54 条
[1]   Dysautonomia and heart rate variability following severe traumatic brain injury [J].
Baguley, Ian J. ;
Heriseanu, Roxana E. ;
Felmingham, Kim L. ;
Cameron, Ian D. .
BRAIN INJURY, 2006, 20 (04) :437-444
[2]   Dysautonomia after traumatic brain injury: a forgotten syndrome? [J].
Baguley, IJ ;
Nicholls, JL ;
Felmingham, KL ;
Crook, J ;
Gurka, JA ;
Wade, LD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (01) :39-43
[3]   Prolonged anti-spasticity effects of bolus intrathecal baclofen [J].
Baguley, IJ ;
Bailey, KM ;
Slewa-Younan, S .
BRAIN INJURY, 2005, 19 (07) :545-548
[4]   Pharmacological management of Dysautonomia following traumatic brain injury [J].
Baguley, IJ ;
Cameron, ID ;
Green, AM ;
Slewa-Younan, S ;
Marosszeky, JE ;
Gurka, JA .
BRAIN INJURY, 2004, 18 (05) :409-417
[5]  
BAGULEY IJ, 2006, BRAIN INJ
[6]   Analgesic effects of botulinum toxin A: a randomized, placebo-controlled clinical trial [J].
Barwood, S ;
Baillieu, C ;
Boyd, R ;
Brereton, K ;
Low, J ;
Nattrass, G ;
Graham, HK .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2000, 42 (02) :116-121
[7]  
BAUGLEY IJ, 2007, J NEUROL NEUROSURG P
[8]   Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury [J].
Becker, R ;
Benes, L ;
Sure, U ;
Hellwig, D ;
Bertalanffy, H .
JOURNAL OF CLINICAL NEUROSCIENCE, 2000, 7 (04) :316-319
[9]   THE CENTRAL AUTONOMIC NETWORK - FUNCTIONAL-ORGANIZATION, DYSFUNCTION, AND PERSPECTIVE [J].
BENARROCH, EE .
MAYO CLINIC PROCEEDINGS, 1993, 68 (10) :988-1001
[10]   Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity [J].
Bensmail, D. ;
Salva, M. A. Quera ;
Roche, N. ;
Benyahia, S. ;
Bohic, M. ;
Denys, P. ;
Bussel, B. ;
Lofaso, F. .
NEUROLOGY, 2006, 67 (08) :1432-1436